CenterHigh
KABC / ABC7 Los AngelesNews report · Aug 6, 9:33 AM
FDA approves Moderna's m RNA seasonal flu vaccine
The vaccine, m FLUSIVA, is expected to be available for people 50 and older for the 2026-2027 respiratory illness season.
← Today's headlines
7 sources checked · 2 source groups included · 26m ago
Still Watching
FDA approves Moderna's m RNA seasonal flu vaccine
Forbes and American Greatness describe the same event in different terms.
0 Left6 Center1 Right
STILL WATCHING
As of August 6, 2026 at 9:33 AM, this is how Optics News reads the wording differences in this story.
What happened The vaccine, m FLUSIVA, is expected to be available for people 50 and older for the 2026-2027 respiratory illness season.
The headline split The center frames it as "FDA approves Moderna's m RNA seasonal flu vaccine". The right frames it as "Morning Greatness: FDA Approves Moderna’s m RNA Seasonal Flu Vaccine".
Match confidence Medium confidence. 7 sources across 2 bias buckets. Useful framing signal — check the source list before sharing.
Same-event confidenceMedium
7 sources across 2 bias buckets agree on the event.
Framing confidenceModerate
56/99 — meaningful wording shift across the spectrum.
WHAT EACH SIDE EMPHASIZED
Left / center-leftNo matching source in this bucket yet.
Optics keeps watching for pickup.
CenterFDA approves Moderna's m RNA seasonal flu vaccine
KABC / ABC7 Los Angeles · Center · News report
Right / center-rightMorning Greatness: FDA Approves Moderna’s m RNA Seasonal Flu Vaccine
American Greatness · Right · News report
SEE THE HEADLINES
Open source
CenterHigh
WLS / ABC7 ChicagoNews report · Aug 6, 9:33 AM
FDA approves Moderna's m RNA seasonal flu vaccine
The vaccine, m FLUSIVA, is expected to be available for people 50 and older for the 2026-2027 respiratory illness season.
CenterHigh
KGO / ABC7 San FranciscoNews report · Aug 6, 9:33 AM
FDA approves Moderna's m RNA seasonal flu vaccine
The vaccine, m FLUSIVA, is expected to be available for people 50 and older for the 2026-2027 respiratory illness season.
CenterHigh
WPVI / 6abc PhiladelphiaNews report · Aug 6, 9:33 AM
FDA approves Moderna's m RNA seasonal flu vaccine
The vaccine, m FLUSIVA, is expected to be available for people 50 and older for the 2026-2027 respiratory illness season.
CenterHigh
KTRK / ABC13 HoustonNews report · Aug 6, 9:33 AM
FDA approves Moderna's m RNA seasonal flu vaccine
The vaccine, m FLUSIVA, is expected to be available for people 50 and older for the 2026-2027 respiratory illness season.
RightMixed
American GreatnessNews report · Aug 6, 9:02 AM
Morning Greatness: FDA Approves Moderna’s m RNA Seasonal Flu Vaccine
Good Thursday morning. Here is what’s on President Trump’s agenda today: 8:00 AM THE PRESIDENT participates in Executive Time 10:00 AM THE PRESIDENT participates in […] Source
Show all 7 sources
CenterMostly Factual
ForbesNews report · Aug 6, 6:44 AM
FDA Approves First m RNA Flu Vaccine For Older Adults
The approval of Moderna’s new flu vaccine comes months after the FDA faced backlash for refusing to review the shot.
Details56/99 Wording Gap · Medium confidence · 7 sources
56/99 Wording GapMedium confidence7 sources · 2 bias bucketsLive match · 7 sources · 2 buckets · comparable news formatFormats: News report
SOURCE MAP CHANGES
Aug 6, 6:44 AM: Forbes joined the source map.
Aug 6, 9:02 AM: American Greatness joined the source map.
Aug 6, 9:33 AM: KABC / ABC7 Los Angeles joined the source map.
Aug 6, 9:33 AM: WLS / ABC7 Chicago joined the source map.
Now: Wording Gap is 56/99 and story health is live match · 7 sources · 2 buckets · comparable news format.